B of A Securities Maintains Neutral on AbbVie, Raises Price Target to $195

Benzinga · 10/18 17:27
B of A Securities analyst Geoff Meacham maintains AbbVie (NYSE:ABBV) with a Neutral and raises the price target from $185 to $195.